Horm Metab Res 2001; 33(5): 256-262
DOI: 10.1055/s-2001-15280
Original Basic
© Georg Thieme Verlag Stuttgart · New York

Regulation of Renal Growth and IGFBP-4 Expression by Triiodothyronine During Rat Development

A. Voci, I. Demori, C. Bottazzi, E. Fugassa
  • Dipartimento di Biologia Sperimentale, Ambientale ed Applicata - Sezione di Fisiologia Generale e Comparata, Università di Genova, Italy
Further Information

Publication History

Publication Date:
31 December 2001 (online)

The insulin-like growth factors (IGFs) and insulin-like growth factor binding proteins (IGFBPs), which regulate IGF activity, play a fundamental role in renal cell proliferation and differentiation. The thyroid hormone is considered to be required for kidney development; excess induces local hypertrophy and hyperplasia. The aim of the present study was to investigate the possible involvement of the IGF/IGFBP system in thyroid hormone-induced renal growth during the development of the rat. Our results show that thyroid hormone withdrawal by 6-propyl-2-thiouracil (PTU)-treatment of rats at all ages had no effect on renal IGFBP-4 mRNA levels, whereas the abundance of the serum protein was decreased compared to controls. Intraperitoneal triiodothyronine (T3) administration to hypothyroid rats resulted in renal hypertrophy associated with a significant upregulation of IGFBP-4 expression with increased levels of renal IGFBP-4 mRNA and serum protein. T3-induced upregulation of IGFBP-4 expression suggests the involvement of the local IGF/IGFBP system in T3-induced renal hypertrophy.

References

  • 1 Froesch E R, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors.  Annual Review of Physiology. 1985;  47 443-467
  • 2 Rechler M M. Insulin-like growth factor binding proteins.  Vitamins and Hormones. 1993;  47 1-114
  • 3 Ferry R J Jr, Katz L E, Grimberg A, Cohen P, Weinzimer S A. Cellular actions of insulin-like growth factor binding proteins.  Hormone and Metabolic Research. 1999;  31 192-202
  • 4 Jones J I, Clemmons D R. Insulin-like growth factors and their binding proteins: biological actions.  Endocrine Reviews. 1995;  16 3-34
  • 5 Daughaday W H, Rotwein P. Insulin-like growth factor I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.  Endocrine Reviews. 1989;  10 68-91
  • 6 Rosenfeld R G, Lamson G, Pham H, Oh Y, Conover C, De Leon D D, Donovan S M, Ocrant I, Giudice L. Insulin-like growth factor binding proteins.  Recent Progress in Hormone Research. 1990;  46 99-163
  • 7 Shapiro L E, Samuels H H. Yaffe BM. Thyroid and glucocorticoid hormones synergistically control growth hormone mRNA in cultured GH1 cells.  Proceedings of the National Academy of Sciences of the USA. 1978;  75 45-49
  • 8 Samuels M H, Wierman M E, Wang C, Ridgway E C. The effect of alterated thyroid status on pituitary hormone messenger ribonucleic acid concentrations in the rat.  Endocrinology. 1989;  124 2277-2282
  • 9 Hochberg Z, Bick T, Harel Z. Alterations of human growth hormone binding by rat liver membranes during hypo- and hyperthyroidism.  Endocrinology. 1990;  126 325-329
  • 10 Gallo G, de Marchis M, Voci A, Fugassa E. Expression of hepatic mRNAs for insulin-like growth factors-I and -II during the development of hypothyroid rats.  Journal of Endocrinology. 1991;  131 367-372
  • 11 Nanto-Salonen K, Rosenfeld R G. Insulin-like growth factor binding protein expression in the hypothyroid rat is age dependent.  Endocrinology. 1992;  131 1489-1496
  • 12 Frystyk J, Gronbaek H. Skjaerbaek C, Flyvbjerg A. Effect of hypothyroidism on circulating levels of free and total IGF-I and IGFBPs in rats.  American Journal of Physiology. 1995;  269 E840-E845
  • 13 Demori I, Bottazzi C, Voci A, Gallo G, Scharf J G, Fugassa E. Triiodothyronine increases insulin-like growth factor protein-4 expression in rat hepatocytes.  Journal of Endocrinology. 1997;  154 155-165
  • 14 Demori I, Bottazzi C, Fugassa E. Tri-iodothyronine increases insulin-like growth factor protein-2 expression in cultured hepatocytes from hypothyroid rats.  Journal of Endocrinology. 1999;  161 465-474
  • 15 Feld S, Hirschberg R. Growth Hormone, the Insulin-like growth factor system, and the kidney.  Endocrine Reviews. 1996;  17 423-480
  • 16 Flyvbjerg A, Kessler U, Dorka B, Funk B, Orskov H, Kiess W. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats.  Diabetologia. 1992;  35 589-593
  • 17 Bradley S E, Stephan F, Coelho J B, Reville P. The thyroid and the kidney.  Kidney International. 1974;  6 346-365
  • 18 Chan Y L, Gutell R, Noller H F, Wool I G. The nucleotide sequence of a rat 18S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18S ribosomal ribonucleic acid.  Journal of Biological Chemistry. 1984;  259 224-230
  • 19 Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for tritation of the binding proteins and competitive binding studies.  Analytical Biochemistry. 1986;  154 138-143
  • 20 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction.  Analytical Biochemistry. 1987;  162 156-159
  • 21 Werner W, Ingbars I. The thyroid. In: Braverman LE, Utiger RD (eds). Philadelphia:; Lippincott-Raven Publishers, 1996 7th ed: 628-631
  • 22 Donovan S M, Oh Y, Priam H, Rosenfeld R G. Ontogeny of serum insulin-like growth factor binding proteins in the rat.  Endocrinology. 1989;  125 2621-2627
  • 23 Ali M, Rougon-Rapuzzi G, Clos J. Response of hypothalamo-neurohypophyseal axis (AVP system) and the kidney to salt load in young propylthiouracil-treated rats.  Hormone and Metabolic Research. 1985;  17 502-506
  • 24 Flyvbjerg A, Bornfeldt K E, Marshall S M, Arnqvist H J, Orskov H. Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats.  Diabetologia. 1990;  33 334-338
  • 25 Gronboek H. Nielsen B. Flyvbjerg A, Orskov H. Effect of graded renal ablation on kidney and serum insulin-like growth factor-I (IGF-I) and IGF binding proteins in rats: relation to compensatory renal growth.  Metabolism. 1997;  46 29-35
  • 26 Koldovsky O. Hormones in milk.  Life Sciences. 1980;  26 1833-1836
  • 27 Miyatake N, Shikata K, Wada J, Sugimoto H, Takahashi S I, Makino H. Differential distribution of insulin-like growth factor-I and insulin-like growth factor binding proteins in experimental diabetic rat kidney.  Nephron. 1999;  81 317-323
  • 28 Demori I, Balocco S, Voci A, Fugassa E. Increased insulin-like growth factor binding protein-4 expression after partial hepatectomy in the rat.  American Journal of Physiology. 2000;  278 G384-G389
  • 29 La Tour D, Mohan S, Linkhart T A, Baylink D J, Strong D D. Inibitory insulin-like growth factor-binding protein: cloning, complete sequence and physiological regulation.  Molecular Endocrinology. 1990;  4 1806-1814
  • 30 Schneider M R, Lahm H, Wu M, Hoeflich A, Wolf E. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins.  Faseb Journal. 2000;  14 629-640
  • 31 Miyakoshi N, Richman C, Qin X, Baylink D J, Mohan S. Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice.  Endocrinology. 1999;  140 5719-5728
  • 32 Rees C, Clemmons D R, Horvitz G D, Clarke J B, Busby W H. A protease-resistant form of insulin-like growth factor (IGF) binding protein-4 inhibits IGF-I actions.  Endocrinology. 1998;  139 4182-4188
  • 33 Fowlkers J, Freemark M. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts.  Endocrinology. 1992;  131 2071-2076
  • 34 Irwin J C, Dsupin B A, Giudice L C. Regulation of insulin-like growth factor binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.  Journal of Clinical Endocrinology and Metabolism. 1995;  80 619-626
  • 35 Singh P, Dai B, Dhruva B, Widen S G. Episomal expression of sense and antisense insulin-like growth factor (IGF) binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I.  Cancer Research. 1994;  54 6563-6570

A. Voci

Dipartimento di Biologia Sperimentale
Ambientale ed Applicata sezione di
Fisiologia Generate e Comparata

Palazzo delle Scienze - corso Europa 26
16132 Genova
Italy


Phone: Phone:+ 39 (10) 3538258

Fax: Fax:+ 39 (10) 3538267

Email: Email:vocia@unige.it

    >